title: [Vulnerability of dopamine circuit development to cytokines from the periphery: implication in schizophrenia].
abstract: Epidermal growth factor (EGF) and neuregulin-1 (NRG) belong to the ErbB ligand family and both exert neurotrophic actions on midbrain dopamine neurons. According to the immune inflammatory hypothesis for schizophrenia, we have established rodent models for this illness by exposing their neonates to these cytokines. At post-pubertal stage, these animals develop various neurobehavioral abnormalities such as prepulse inhibition (PPI) and social interaction deficits. In this review, we introduce neurochemical features of the EGF-treated rats and NRG-treated mice, which exhibit persistent increases in tyrosine hydroxylase levels and dopamine release in the globus pallidus and prelimbic cortex (medial prefrontal cortex), respectively. Local blockade of the hyperdopaminergic state in EGF-treated rats ameliorates their behavioral deficits. These findings suggest that development of the midbrain dopamine system is vulnerable to circulating cytokines at perinatal and/or prenatal stages and potentially influences schizophrenia risk or neuropathology. The dopamine hypothesis for schizophrenia is re-evaluated with the obtained results as well as with published literatures in this review.
authors.affiliation: Molecular Neurobiology, Brain Research Institute, Niigata University, Asahimachi, Japan.
authors.forename: Hidekazu
authors.initials: H
authors.lastname: Sotoyama
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Nawa
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D004298:Dopamine / Q000502:physiology*; D004815:Epidermal Growth Factor / Q000009:adverse effects / Q000502:physiology*; D066246:ErbB Receptors; D005917:Globus Pallidus / Q000378:metabolism; D006801:Humans; D008024:Ligands; D051379:Mice; D009411:Nerve Endings / Q000502:physiology; D020890:Neuregulin-1 / Q000009:adverse effects / Q000502:physiology*; D017397:Prefrontal Cortex / Q000378:metabolism; D051381:Rats; D012559:Schizophrenia / Q000209:etiology*; D012920:Social Behavior Disorders / Q000209:etiology / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
chemical_list: D008024:Ligands; C094131:NRG1 protein, human; D020890:Neuregulin-1; D004815:Epidermal Growth Factor; D014446:Tyrosine 3-Monooxygenase; C512478:EGFR protein, human; D066246:ErbB Receptors; D004298:Dopamine